+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID07059884

Virtual Exercise Program to Maintain Function and Prevent Disability in Cancer Patients Undergoing Chemotherapy

Led by Alliance for Clinical Trials in Oncology · Updated on 2026-11-04

104

Participants Needed

30

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating whether a virtual exercise program can be effectively delivered to cancer patients receiving chemotherapy. The study aims to help patients maintain strength and reduce fatigue caused by cancer treatments, which can interfere with daily activities and work. This supportive care trial focuses on patients with various localized malignant solid tumors undergoing curative-intent chemotherapy. Participants follow a supervised exercise program via telehealth video calls that include resistance and aerobic exercises. They complete supervised aerobic and resistance sessions twice a week and additional unsupervised aerobic exercises weekly, continuing until the end of their chemotherapy or up to six months. Patients receive exercise equipment such as a stationary bike, dumbbells, resistance bands, and wear an accelerometer to monitor activity. During the study, researchers monitor exercise session completion, patient retention, and physical function changes using tests like the 6 Minute Walk Test and grip strength. Patients also complete questionnaires and interviews about their physical activity and quality of life. Follow-up assessments occur four weeks and three months after the intervention, with total participation lasting up to six months or until chemotherapy completion.

CONDITIONS

Brief Title

Distance-Based Exercise to Preserve Function and Prevent Disability

Research Team

L

Lilli Johnson

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here